Skip to main content
. 2021 Feb 7;27(5):404–415. doi: 10.3748/wjg.v27.i5.404

Table 2.

Clinical and pathological parameters of hepatitis C virus patients by pretreatment and posttreatment predominantly progressive, indeterminate and predominately regressive score (n = 23)

Parameters Progressive Indeterminate Regressive P value
Pretreatment, n (%) 15 (65) 7 (30) 1 (4)
Age (yr) 50.3 ± 12.3 43.9 ± 12.5 27.0 0.154
Males, n (%) 6 (40) 3 (43) 0 (0) 0.709
ALT (U/L) 66 (57) 48 (38) 50 (0) 0.469
TBil (μmol/L) 14.0 (8.0) 12.0 (6.0) 9.0 (0.0) 0.642
Albumin (g/L) 44.0 ± 3.9 47.0 ± 3.1 45.0 0.233
Platelets (× 103 μL) 129.3 ± 60.2 188.0 ± 51.5 268.0 0.024
INR 1.04 (0.16) 1.00 (0.2) 1.00 (0.00) 0.307
HCV RNA (log IU/L) 6.01 ± 0.66 6.46 ± 0.90 6.60 0.375
LSM, kPa 8.8 (14.8) 6.6 (2.9) 6.6 (0.0) 0.331
HAI score, n (%) 0.070
0-3 0 (1) 1 (14) 0 (0)
4-6 1 (7) 2 (29) 1 (100)
7-9 4 (27) 3 (43) 0 (0)
≥ 10 10 (67) 1 (14) 0 (0)
Ishak score, n (%) 0.072
3-4 4 (27) 5 (71) 1 (100)
5-6 11 (73) 2 (29) 0 (0)
Posttreatment, n (%) 5 (22) 9 (39) 9 (39)
Age (yr) 50.4 ± 12.0 47.8±14.1 45.4 ± 13.4 0.802
Males, n (%) 1 (20) 3 (33) 5 (56) 0.384
ALT (U/L) 25 (21) 17 (8) 15 (15.5) 0.340
TBil (μmol/L) 19 (10) 10 (6) 14 (9) 0.149
Albumin (g/L) 44.0 ± 4.2 44.9 ± 1.9 46.0 ± 1.8 0.353
Platelets (× 103 μL) 156.4 ± 63.3 184.4 ± 80.3 151.1 ± 65.8 0.552
INR 1.13 (0.15) 1.00 (0.14) 1.09 (0.15) 0.052
LSM, kPa 11.5 (22.8) 7.8 (7.4) 6.8 (5.2) 0.683
HAI score, n (%) 0.338
0-3 1 (20) 4 (44) 6 (67)
4-6 2 (40) 4 (44) 3 (33)
7-9 1 (20) 0 (0) 0 (0)
≥ 10 1 (20) 1 (11) 0 (0)
Ishak score, n (%) 0.339
3-4 2 (40) 6 (67) 6 (67)
5-6 3 (60) 3 (33) 3 (33)

ALT: Alanine aminotransferase; TBil: Total bilirubin; INR: International normalized ratio; HCV: Hepatitis C virus; LSM: Liver stiffness measurement; HAI: Histology activity index.